"The U.S. Food and Drug Administration today expanded the approved use of Zytiga (abiraterone acetate) to treat men with late-stage (metastatic) castration-resistant prostate cancer prior to receiving chemotherapy.
The FDA initially appr"...
(Generic versions may still be available.)
- Clinician Information:
Plenaxis Patient Information including If I Miss a Dose
In this Article
- What is abarelix (Plenaxis)?
- What are the possible side effects of abarelix (Plenaxis)?
- What is the most important information I should know about abarelix (Plenaxis)?
- What should I discuss with my healthcare provider before using abarelix (Plenaxis)?
- How should I use abarelix (Plenaxis)?
- What happens if I miss a dose (Plenaxis)?
- What happens if I overdose (Plenaxis)?
- What should I avoid while using abarelix (Plenaxis)?
- What other drugs will affect abarelix (Plenaxis)?
- Where can I get more information?
What happens if I miss a dose (Plenaxis)?
Contact your doctor if you miss a dose of abarelix.
What happens if I overdose (Plenaxis)?
An overdose of abarelix is unlikely to occur. If you do suspect that an overdose has occurred, contact your doctor, hospital emergency room, or poison control center for advice.
What should I avoid while using abarelix (Plenaxis)?
There are no restrictions on food, beverages, or activities while using abarelix. Follow any special instructions given by your doctor.
What other drugs will affect abarelix (Plenaxis)?
It is not known whether abarelix will interact with other medicines. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including herbal products during treatment with abarelix.
Where can I get more information?
Your pharmacist has additional information about abarelix written for health professionals that you may read.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2009 Cerner Multum, Inc. Version: 1.02. Revision date: 2/13/04.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Plenaxis Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.